Detection of glioblastoma response to temozolomide combined with bevacizumab based on mu MRI and mu PET imaging reveals [F-18]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy
| Auteurs | Corroyer-Dulmont A, Peres EA, Petit E, Guillamo JS, Varoqueaux N, Roussel S, Toutain J, Divoux D, MacKenzie ET, Delamare J, Ibazizene M, Lecocq M, Jacobs AH, Barre L, Bernaudin M, Valable S |
| Revue | |
| Institut | I2BM |
| Année | 2 013 |